Description

Revmoxicam (Meloxicam) Solution for Injection Ampoules 1% 1.5 ml. №5

Ingredients

Active ingredient: Meloxicam
Other ingredients: Sodium chloride, glycocholic acid, water for injections.

Dosage

Dosage: The usual dose is 7.5 mg once daily. For the treatment of acute pain, an initial dose of 15 mg is recommended.
Administration: For intramuscular use only.

Indications

Revmoxicam (Meloxicam) Solution for Injection Ampoules is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

Contraindications

Do not use Revmoxicam (Meloxicam) Solution for Injection Ampoules if you have a history of allergic reactions to meloxicam or other NSAIDs, active peptic ulcer, severe heart failure, or during the third trimester of pregnancy.

Directions

Directions for use: Administer the injection as directed by a healthcare professional. Do not exceed the recommended dose or duration of treatment.

Scientific Evidence

Meloxicam, the active ingredient in Revmoxicam, is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties. Studies have shown that meloxicam effectively reduces pain and inflammation in various musculoskeletal conditions. Research published in the Journal of Clinical Rheumatology demonstrated the efficacy of meloxicam in improving physical function and reducing pain in patients with osteoarthritis.

Additional Information

It is important to monitor for signs of gastrointestinal bleeding, cardiovascular events, and renal impairment while using meloxicam. Consult a healthcare provider before starting treatment with Revmoxicam (Meloxicam) Solution for Injection Ampoules. Store the ampoules at room temperature away from light and moisture.

Pharmacological Effects: Meloxicam works by inhibiting the enzyme cyclooxygenase, thereby reducing the production of prostaglandins that cause pain and inflammation. This results in pain relief and improved function in conditions such as arthritis.

Clinical Trials: Clinical trials have shown that meloxicam is as effective as other NSAIDs in managing pain and inflammation associated with arthritis, with a lower risk of gastrointestinal side effects. A study published in the journal Drugs & Aging compared meloxicam with diclofenac and found similar efficacy but a lower incidence of gastrointestinal complications with meloxicam.